CARM — Carisma Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $45.70m
- -$8.56m
- $14.92m
Annual cashflow statement for Carisma Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -108 | -22.4 | -0.336 | -19.9 | -86.9 |
| Depreciation | |||||
| Non-Cash Items | 72.9 | -9.42 | -20 | -18.2 | 8.3 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -3.1 | 0.861 | -48.6 | 63 | -5.44 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -37.5 | -30.8 | -68.9 | 24.9 | -81.2 |
| Capital Expenditures | -0.136 | -0.008 | -0.004 | — | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -54 | 73.5 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.136 | -0.008 | -0.004 | -54 | 72.4 |
| Financing Cash Flow Items | — | — | -0.001 | — | 31.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 35.4 | 38.1 | 176 | 0.001 | 62.2 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -2.3 | 7.27 | 107 | -29.1 | 53.4 |